Why this matters
Most major insurers cover TMS — with specific criteria
TMS is an FDA-cleared, noninvasive treatment for major depressive disorder (MDD). Insurers approve it when medical necessity is documented. At Florida TMS Clinic, we manage the entire authorization process for you — from verifying benefits to submitting prior-auth with the right clinical details.
What insurers look for
- Diagnosis: MDD (single or recurrent), often severe or treatment-resistant.
- Medication trials: Most plans require at least two adequate trials; Medicare may accept one; Humana may require four.
- Objective scales: We collect baseline and follow-up scores (PHQ-9, HAM-D, MADRS).
- Intolerance counts: Significant side effects can qualify as “failed.”
Our clinicians document dose, duration, efficacy, and side effects for a clean submission and quicker approvals.